Recent Research on Waldenstrom Macroglobulinemia Treatment
Scientists are studying how these developments of normal lymphocytes open the way for Waldenstroms Macroglobulinemia to develop.
- (1888PressRelease) June 08, 2011 - American cancer society- Scientists have recently researched the latest treatment methods for the rare cancer, Waldenstroms Macroglobulinemia. The American Cancer Society has developed some ways to treat Waldenstroms Macroglobulinemia which are showing some promise. They are currently researching on how a change in DNA causes the development of the lymphoma cancer. The DNA study has revealed that the development of genes in certain translocation causes an increase in white blood cells.
The white blood cells that grow rapidly in the body makes the immune system unusually slow and inoperative, they also create abnormal reactions in the body. Scientists are studying how these developments of normal lymphocytes open the way for Waldenstroms Macroglobulinemia to develop. Once they understand the process they will start the treatment process to stop the growth of the cancer.
Genetics scientists are also investigating in detail about chemotherapy, one of the best treatments for cancer. The study has revealed that the chemotherapy drugs are still the most useful in treating Waldenstroms Macroglobulinemia. Combining the drugs in different ways, can be an effective way to cure the cancer.
The research on anti cholesterol medicine, which helps to lower the lgm levels, has shown it can also be used in treatment for Waldenstroms Macroglobulinemia. Though it is stated that this medicine has several side effects, it can still be useful in healing Waldenstroms Macroglobulinemia. Another noteworthy medication found by the doctors is biological therapy. It is a totally new approach where the patient's own immune system can fight the cancer.
It has recently been discovered that the bone marrow tissues (stromal cells) produce a chemical called interleukin 6 (IL-6). IL-6 is a strong escalation factor for multiple myeloma cells. IL-6 also helps by causing the bone demolition of the myeloma cells. According to the American cancer society the current study efforts are focused on trying to build up ways to block the purpose of IL-6.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam